Variables Total (n = 58) pure (n = 31) mixed (n = 27) P value
Age(y), n (%) Age(y), n (%) 0.847
≤45 33 (56.9) 18 (58.1) 15 (55.6)
>45 25 (43.1) 13 (41.9) 12 (44.4)
Stage, n (%) Stage, n (%) 0.735
IA2-IB3 24 (41.4) 12 (38.7) 12 (44.4)
IIA1-IIA2 18 (31.0) 11 (35.5) 7 (25.9)
IIIC 16 (27.6) 8 (25.8) 8 (29.6)
Tumor size, n (%) Tumor size, n (%) 0.766
≤4cm 44 (75.9) 24 (77.4) 20 (74.1)
>4cm 14 (24.1) 7 (22.6) 7 (25.9)
NACT, n (%) 0.240
No 55 (94.8) 28 (90.3) 27 (100)
Yes 3 (5.2) 3 (9.7) 0 (0.0)
Adjuvant therapy, n(%) Adjuvant therapy, n(%) 0.506
No 5 (8.6) 3 (9.7) 2 (7.4)
Chemotherapy 37 (63.8) 17 (54.8) 20 (74.1)
Radiotherapy 13 (22.4) 9 (29) 4 (14.8)
Both 3 (5.2) 2 (6.5) 1 (3.7)
Chemotherapy, n (%) Chemotherapy, n (%) 0.704
Non 8 (13.8) 5 (16.1) 3 (11.1)
Non etoposide + platinum 31 (53.4) 15 (48.4) 16 (59.3)
etoposide + platinum 19 (32.8) 11 (35.5) 8 (29.6)
Radiotherapy,n (%) Radiotherapy,n (%) 0.268
No 17 (29.3) 11 (35.5) 6 (22.2)
Yes 41 (70.7) 20 (64.5) 21 (77.8)
Gravidity, n (%) 0.134
≤3 36 (62.1) 22 (71.0) 14 (51.9)
>4 22 (37.9) 9 (29.0) 13 (48.1)
Parity, n (%) 0.712
≤2 50 (86.2) 26 (83.9) 24 (88.9)
>3 8 (13.8) 5 (16.1) 3 (11.1)
Diabetes, n (%) Diabetes, n (%) 1
No 53 (91.4) 28 (90.3) 25 (92.6)
Yes 5 (8.6) 3 (9.7) 2 (7.4)
Hypertension, n (%) Hypertension, n (%) 1
No 51 (87.9) 27 (87.1) 24 (88.9)
Yes 7 (12.1) 4 (12.9) 3 (11.1)
Family history, n (%) 0.712
No 50 (86.2) 26 (83.9) 24 (88.9)
Yes 8 (13.8) 5 (16.1) 3 (11.1)
Time of operation, (Mean ± SD)
192.9 ± 56.4
196.6 ± 48.7
188.7 ± 64.8
0.6
Type of operation, n (%) Type of operation, n (%) 0.565
Laparoscopic surgery 33 (56.9) 16 (51.6) 17 (63.0)
Robotic surgery 18 (31.0) 10 (32.3) 8 (29.6)
Open surgery 7 (12.1) 5 (16.1) 2 (7.4)
Keep ovarian, n (%) Keep ovarian, n (%) 0.864
No 38 (65.5) 20 (64.5) 18 (66.7)
Yes 20 (34.5) 11 (35.5) 9 (33.3)
Bleeding(ml), Mean ± SD 167.4 ± 295.6 163.5 ± 191.8 171.9 ± 386.2 0.916
Lymph node metastasis, n (%) Lymph node metastasis, n (%) 0.530
No 41 (70.7) 23 (74.2) 18 (66.7)
Yes 17 (29.3) 8 (25.8) 9 (33.3)
Perineural invasive, n (%) Perineural invasive, n (%) Perineural invasive, n (%) 1
No 51 (87.9) 27 (87.1) 24 (88.9)
Yes 7 (12.1) 4 (12.9) 3 (11.1)
LVSI, n (%) 0.408
No 31 (53.4) 15 (48.4) 16 (59.3)
Yes 27 (46.6) 16 (51.6) 11 (40.7)
Uterus invasion, n (%) Uterus invasion, n (%) 0.675
No 52 (89.7) 27 (87.1) 25 (92.6)
Yes 6 (10.3) 4 (12.9) 2 (7.4)
Parametrium invasion, n (%) Parametrium invasion, n (%) Parametrium invasion, n (%) 0.116
No 54 (93.1) 27 (87.1) 27 (100)
Yes 4 (6.9) 4 (12.9) 0 (0.0)
Surgical margins, n (%) Surgical margins, n (%) Surgical margins, n (%) 0.494
No 56 (96.6) 29 (93.5) 27 (100)
Yes 2 (3.4) 2 (6.5) 0 (0.0)
Depth of stromal invasion, n (%) Depth of stromal invasion, n (%) Depth of stromal invasion, n (%) 0.788
≤1/3 12 (20.7) 6 (19.4) 6 (22.2)
>2/3 46 (79.3) 25 (80.6) 21 (77.8)